Daewoong Pharmaceutical's Easydew Achieves 100 Billion Won in Annual Sales Ahead of Schedule

Accelerating Expansion into Japan, the United States, and Southeast Asia
Easydew Achieves Early Annual Sales Milestone and Strengthens Global Beauty Market Strategy

Daewoong Pharmaceutical announced on September 2 that its dermocosmetic brand Easydew has achieved annual sales of 100 billion won ahead of schedule. As of July, Easydew’s cumulative sales exceeded 100 billion won, representing an increase of approximately 200% compared to the same period last year.

Easydew Blemish Ampoule. Daewoong Pharmaceutical

The competitiveness of Easydew’s products lies in DW-EGF (highly active epidermal growth factor), Korea’s first bio new drug developed by Daewoong Pharmaceutical. DW-EGF is gaining attention in the dermocosmetic market for its powerful skin regeneration effects. In particular, Easydew’s DW-EGF consists of exactly 53 amino acids, identical to human EGF, which means it has a structure that is 100% the same as endogenous EGF (epidermal growth factor).

Easydew further demonstrated its brand power by being selected as the number one beauty brand on Lotte Home Shopping in the first half of this year. The acquisition of new customers through Easydew’s official online store and a high repurchase rate also contributed to the expansion of sales. According to market research firm Embrain, Easydew ranked first in repurchase rate in this year’s index survey for blemish and pigmentation cosmetic brands, securing a loyal customer base.

Easydew’s flagship product is the “Blemish Ampoule (DW-EGF Melatoning One Day Ampoule).” Containing DW-EGF (highly active epidermal growth factor) for blemish care and functional whitening ingredients, it addresses concerns related to pigmentation such as blemishes and dark spots. The efficacy of the Blemish Ampoule has been clinically proven, and its whitening and skin tone improvement effects are driving an increase in market share.

The “Blemish Cushion,” modeled by actress Han Gain, also contributed to the increase in sales. The Blemish Cushion differentiates itself by offering not only blemish coverage but also actual blemish improvement, and has achieved cumulative sales of over 40 billion won since its launch. In human application tests, the Blemish Cushion demonstrated a 32% reduction in the number of dark blemishes and a 42% reduction in blemish area after just one day of use.

An Easydew representative stated, “Achieving annual sales of 100 billion won ahead of schedule is a valuable result made possible by the trust and choices of our consumers. Based on the efficacy of DW-EGF, we plan to offer a wider range of solutions at the brand level so that more consumers can quickly resolve their skin concerns.” The representative added, “Going forward, Daewoong Pharmaceutical’s Easydew will establish itself as a leading Korean dermocosmetic brand not only in Korea but also in the global beauty market, including Japan, the United States, and Southeast Asia, through consumer-tailored strategies.”

This content was produced with the assistance of AI translation services.